title: Molecular variant of hairy cell leukemia with poor prognosis.
abstract: Hairy cell leukemia variant (HCLv), described 30 years ago, was reported to present with high disease burden and less often leukopenia, and later was reported to be resistant to purine analogs. Patients with HCLv were overrepresented among patients with HCL seeking relapsed/refractory trials. To compare clinical and molecular features of classic HCL (HCLc) and HCLv, 85 rearrangements expressing immunoglobulin variable heavy chain were sequenced, taken from 20 patients with HCLv and 62 with HCLc. The gene VH4-34, commonly used in autoimmune disorders, was found in eight patients (40%) with HCLv versus six (10%) with HCLc (p = 0.004). Ninety-three percent of the VH4-34 rearrangements were unmutated, defined as >98% homologous to the germline sequence. Clinical features of VH4-34+ patients that were similar to those with HCLv included higher white blood cell counts at diagnosis (p = 0.002) and lower response (p = 0.00001) and progression-free survival (p = 0.007) after first-line cladribine, and shorter overall survival from diagnosis (p < 0.0001). It was found that VH4-34 was independent from HCLv and a stronger predictor than HCLv in associating with poor prognosis. We conclude that VH4-34+ hairy cell leukemia, which only partly overlaps with HCLv, is associated with poor prognosis after single-agent cladribine. However, cases are observed which respond well to antibody therapy either alone or in combination with purine analog.
authors: Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
authors: Evgeny
authors: E
authors: Arons
authors: Robert J
authors: RJ
authors: Kreitman
references: Blood. 1996 Apr 1;87(7):2846-52
references: 8639903
references: N Engl J Med. 2001 Jul 26;345(4):241-7
references: 11474661
references: Haematologica. 2008 May;93(5):697-705
references: 18387977
references: Clin Cancer Res. 2006 May 1;12(9):2804-11
references: 16675574
references: J Clin Oncol. 2009 Jun 20;27(18):2983-90
references: 19414673
references: J Clin Invest. 1997 May 15;99(10):2488-501
references: 9153293
references: Clin Lymphoma Myeloma. 2007 Nov;7(9):573-9
references: 18186965
references: Br J Haematol. 2006 Jun;133(5):504-12
references: 16681637
references: Blood. 2009 Nov 19;114(21):4687-95
references: 19745070
references: Leukemia. 2001 Jan;15(1):184-6
references: 11243388
references: Best Pract Res Clin Haematol. 2003 Mar;16(1):41-56
references: 12670464
references: Blood. 2008 Feb 1;111(3):1524-33
references: 17959859
references: Leuk Res. 1980;4(6):547-59
references: 7206776
references: Blood. 2006 Jun 15;107(12):4658-62
references: 16497968